Skip to content

Efficacy of Oral Nutritional Supplement in Community-Dwelling Adults Following Acute Care

Efficacy of Oral Nutritional Supplementation Added to Usual Care in Community-dwelling Adults at Risk of Malnutrition and With Low Muscle Strength Following Acute Care

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07753239
Enrollment
304
Registered
2026-08-07
Start date
2026-10-01
Completion date
2028-01-01
Last updated
2026-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Muscle Strength, Malnutrition

Keywords

Oral nutritional supplement, Malnutrition, Nutritional risk, Low muscle strength, Handgrip strength, Post-discharge, Older adults, Body weight, Physical function, Sarcopenia

Brief summary

The study aims to determine the effects of Oral Nutritional Supplement (ONS) added to usual care on body weight compared with usual care alone in community-dwelling adults aged 55 years and older who are at risk of malnutrition and have low muscle strength following acute care. Participants randomized to receive either ONS twice daily for 180 days plus usual care, or usual care alone. Usual care includes individualized dietary counseling and standardized physical activity advice provided. The study will assess body weight, nutritional status, muscle strength, physical function, dietary intake, and safety outcomes.

Interventions

DIETARY_SUPPLEMENTONS

230 mL per serving, twice daily

OTHERStandard of Care (SOC)

Dietary counseling and physical activity advice

Sponsors

Abbott Nutrition
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Intervention model description

Prospective, multicenter, randomized, controlled, open-label, parallel-design study.

Eligibility

Sex/Gender
ALL
Age
55 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

1. At risk of malnutrition. 2. At the point of hospital discharge, the admission was for an acute medical illness. 3. Has low maximum handgrip strength. 4. Estimated life expectancy of more than 12 months. 5. Community ambulant. 6. No other chronic disease. 7. Able to communicate and follow instructions. 8. Able to consume food and beverages orally. 9. Willing to refrain from taking non-study oral nutritional supplements over the course of the study. 10. Able and willing to follow study procedures.

Exclusion criteria

1. Index hospitalization admission was for a surgical procedure or a stroke/myocardial infarction. 2. Diagnosed with type 1 or type 2 diabetes. 3. Has an active infectious disease. 4. Diagnosed with severe gastrointestinal disorders. 5. With severe or unstable congestive heart failure. 6. With chronic kidney disease stage 2 or higher, end-stage organ failure, or other pre-terminal condition. 7. Has an active malignancy within the past five years or currently receiving treatment for malignancy. 8. Has a severe or unstable musculoskeletal or neuromuscular disorder. 9. Unable to perform a valid handgrip strength assessment. 10. Any condition that makes the participant unsuitable for the study. 11. Currently enrolled in another clinical study. 12. Has an eating disorder, alcoholism or substance abuse. 13. Has dementia, delirium, or a significant neurological or psychiatric disorder. 14. Known allergy or intolerance to any ingredients of the study product. 15. Continuous use of ONS for 14 days prior to the baseline visit. 16. Has used herbal products, dietary supplements, or medications in the past 30 days that could affect body weight, appetite, or body composition. 17. Presence of clinically significant ascites, pleural effusion, edema, or dehydration.

Design outcomes

Primary

MeasureTime frameDescription
Change in body weightDay 0 to Day 180Measured in kg

Secondary

MeasureTime frameDescription
Change in body weightStudy Day 30, Study Day 90 and Study Day 180Measured in kg
Body mass index (BMI)Study Day 30, Study Day 90 and Study Day 180Calculated as Weight (kg)/Height (m)2
Calf circumferenceStudy Day 30, Study Day 90 and Study Day 180Measured in cm
Mid-upper arm circumference (MUAC)Study Day 30, Study Day 90 and Study Day 180Measured in cm
Body compositionStudy Day 30, Study Day 90 and Study Day 180Body composition variables assessed by bioelectrical impedance analysis (BIA), including appendicular skeletal muscle mass, lean mass, fat-free mass, fat mass, and derived indices.
Nutrition RiskStudy Day 30, Study Day 90 and Study Day 180Nutritional Risk Screening (NRS-2002) is a clinical tool used to identify persons at risk of malnutrition. It classifies participants into one of the 2 categories: 1. Score of \< 3 = Low risk 2. Score of ≥ 3 = At nutritional risk
Handgrip strengthStudy Day 30, Study Day 90 and Study Day 180Maximum handgrip strength assessed using the Jamar dynamometer.
Short Physical Performance Battery (SPPB) total scoreStudy Day 30, Study Day 90 and Study Day 180Short Physical Performance Battery total score ranges from 0 to 12; higher scores indicate better physical performance.
Short Physical Performance Battery (SPPB) component scoresStudy Day 30, Study Day 90 and Study Day 180Balance, 4-meter gait speed, and chair stand component scores; higher scores indicate better performance.
4-meter gait speedStudy Day 30, Study Day 90 and Study Day 1804-meter gait speed, measured in meters per second.
Chair stand timeStudy Day 30, Study Day 90 and Study Day 180Chair stand time, measured in seconds.
Energy, macronutrient and micronutrient intakesStudy Day 30, Study Day 90 and Study Day 18024-Hour Dietary Recall: Researcher-led interview on food and drink intake the previous day. Nutrient analysis will be performed using a dietary analysis program.
Energy, macronutrient and micronutrient adequacyStudy Day 30, Study Day 90 and Study Day 180Nutrient adequacy will be determined by comparing nutrient intakes (outcome No. 10) against sex- and age- specific local recommended nutrient intakes (RNI).

Countries

Thailand

Contacts

CONTACTMei Qi Mak
meiqi.mak@abbott.com+65 6801 6272
STUDY_CHAIRMandy Yen Ling Ow, Ph.D.

Abbott Nutrition

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 8, 2026